The proliferation of enhancement technologies and pharmacological agents has perpetuated the view of American doctors and patients of medical care as a market commodity driven by what consumers want and are willing to pay for.

A plastic surgeon criticizes reality television programs that focus on plastic surgery for their less-than-realistic depictions of cosmetic procedures and the profession as a whole.

Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts.

A bioethicist argues that children with Down syndrome should not be subjected to cosmetic surgery to change their appearance unless they are at the age and have the capacity to make the decision for themselves.

Nathaniel Hawthorne's book The Birthmark is examined along with the current medical ramifications of the morals and lessons found within the story.

Major medical and ethical problems remain to be resolved before face transplantation surgery is attempted with human patients.

Physicians need to inform parents about the limited effectiveness of growth hormone therapy in satisfying the treatment goals of children with idiopathic short stature.

Physicians need to inform parents about the limited effectiveness of growth hormone therapy in satisfying the treatment goals of children with idiopathic short stature.

Physicians need to inform parents about the limited effectiveness of growth hormone therapy in satisfying the treatment goals of children with idiopathic short stature.

A physician's role in controlling the abuse of performance-enhancing drugs includes educating patients about the harms associated with these drugs and encouraging them to adopt safe and appropriate training programs.